
Glass House Brands Reports Second Quarter 2025 Financial Results
Glass House Brands Reports Second Quarter 2025 Financial Results

Glass House Brands Reports Second Quarter 2025 Financial Results
Satellos Reports Second Quarter 2025 Results and Highlights Upcoming Clinical Milestones
NexgenRx's Q2 2025 revenue at $4.34-million
Eupraxia's June 30 cash balance at $19.8-million (U.S.)
Spectral's PMX reduces mortality in septic shock trial
Ocumetics nears first human lens implant
Biomark enters partnership with Sama in Tunisia
Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for Injection
Hydreight talks VSDHOne order growth
Quipt Home Medical to form JV with three health systems
Genix Pharmaceuticals arranges $100,000 financing
Rakovina Therapeutics signs LOI for JV with NanoPalm
Revive closes $60,900 first tranche of placement
Perimeter estimates Q2 2025 revenue of $500,000 (U.S.)
Pharmather's KETARx approved by FDA